Current literary information concerning the properties of stem cells

Authors

DOI:

https://doi.org/10.26641/1997-9665.2021.3.17-22

Keywords:

stem cells, regeneration, pluripotency, cord blood

Abstract

The literary research deals with the review of literary data concerning the main properties of stem cells. Treatment by means of cells of this specific type able to self-generation and at the same time to be transformed into other specialized cells during cell division enables to cause a real revolution in the world medicine. Therapeutic effect of stem cells opens unlimited prospects for the treatment of a number of genetic and acquired diseases. Biology of the stem cells deserves special attention due to the fact that stem cells are able to exist both in the body and outside. At the present stage of development of the world science stem cells arouse interest among scientists since they are a pattern to study the processes of early embryogenesis, differentiation of tissues, and regeneration of organs. One should take account of the fact that according to the recent data stem cells are the main component in the development of malignant tumor processes. The main properties of stem cells are: self-renewal – ability to maintain unchanged phenotype after division; universality – lack of specific structures enabling them to perform certain functions, though they are able to transform into any body cell; potency – differentiating potential, ability to produce progeny in the form of specialized types of cells. Our review of scientific literature dealing with the issues of investigation of stem cells on the whole and introduction of the cord blood used in the medical therapeutic practice of trophic ulcers by stem cells are indicative of a considerable interest of scientists in this subject. It is confirmed by a number of publications dealing with investigation of properties of stem cells. Meanwhile, a striking qualitative and quantitative difference of the domestic and foreign scientific literary sources should be mentioned here in favour of the latter ones. Therefore, it should be reasonable to indicate an insufficient number of high quality scientific researches described dealing with treatment of trophic ulcers by domestic scientists. The majority of such works is fragmentary and incomplete. At the same time, foreign scientific literary sources contain disputable and sometimes not wellreasoned statements. Therefore, the subject of our study is considered to be an urgent problem.

References

  1. Kiselev SL, Lagarkova MA. [Stem cells and genetic reprogramming]. Vavilov Journal of Genetics and Breeding. 2013;17(2):851-863. Russian
  2. Zolotukhina EL. [Stem cells and prospects for their use in dentistry and maxillofacial surgery]. Young Scientist. 2014;09(6):145-147. Russian
  3. Cedar SH, Minger SL. Human embryonic stem cells: A model for human aging in vitro. Experimental gerontology. 2008;43:1005-1008.
  4. Flores I, Blasco MA. The role of telomerase in stem cell aging. FEBS Letters. 2010;584:3826-3830.
  5. Huang J, Liu X, Li D, Shao Z, Cao H, Zhang Y, Trompouki E. Dynamic Control of Enhancer Repertoires Drives Lineage and Stage-Specific Transcription during Hematopoiesis. Dev Cell. 2016;36(1):9-23. DOI: 10.1016/j.devcel.2015.12.014.
  6. Anderson H, Patch TC, Reddy PN, Hagedorn EJ, Kim PG, Soltis KA, Chen MJ. Hematopoietic stem cells develop in the absence of endothelial cadherin 5 expression. Blood. 2015;126(26):2811-2820. DOI: 10.1182/blood-2015-07-659276.
  7. Merrikh-Bayat F, Guo X, Klachko M, Prezioso M, Likharev KK, Strukov DB. High-Performance Mixed-Signal Neurocomputing With Nanoscale Floating-Gate Memory Cell Arrays. IEEE Trans Neural Netw Learn Syst. 2018;29(10):4782-4790. DOI: 10.1109/TNNLS.2017.2778940.
  8. Aversa F, Prezioso L, Manfra I, Galaverna F, Spolzino A, Monti A. Immunity to Infections after Haploidentical Hematopoietic Stem Cell Transplantation. Mediterr J Hematol Infect Dis. 2016;8(1):e2016057.
  9. Johnson S, Atala A. Regenology: Time for a New Specialty? Stem Cells Transl Med. 2018;8(1):4–6. DOI: 10.1002/sctm.18-0101.
  10. Wan Q, Xiong G, Liu G, Shupe TD, Wei G, Zhang D, Liang D. Urothelium with barrier function differentiated from human urine-derived stem cells for potential use in urinary tract reconstruction. Stem Cell Res Ther. 2018;9(1):304. DOI: 10.1186/s13287-018-1035-6.
  11. Zarandi NP, Galdon G, Kogan S, Atala A, Sadri-Ardekani H. Cryostorage of immature and mature human testis tissue to preserve spermatogonial stem cells (SSCs): a systematic review of current experiences toward clinical applications. Stem Cells Cloning. 2018;11:23-38. DOI: 10.2147/SCCAA.S137873.
  12. Liu G, Wu R, Yang B, Deng C, Lu X, Walker SJ, Ma PX. Human Urine-Derived Stem Cell Differentiation to Endothelial Cells with Barrier Function and Nitric Oxide Production. Stem Cells Transl Med. 2018;7(9):686-698. DOI: 10.1002/sctm.18-0040.
  13. Mokhtari S, Colletti E, Yin W, Sanada C, Lamar Z, Simmons PJ, Walker S. Correction: A human bone marrow mesodermal-derived cell population with hemogenic potential. Leukemia. 2018;32(7):1670. DOI: 10.1038/s41375-018-0172-3.
  14. Matz EL, Terlecki R, Zhang Y, Jackson J, Atala A. Stem Cell Therapy for Erectile Dysfunction. Sex Med Rev. 2019;7(2):321–328. DOI: 10.1016/j.sxmr.2017.12.008.
  15. Mokhtari S, Colletti E, Yin W, Sanada C, Lamar Z, Simmons PJ, Walker S. A human bone marrow mesodermal-derived cell population with hemogenic potential. Leukemia. 2018;32(7):1575-1586. DOI: 10.1038/s41375-018-0016-1.
  16. Atala A. Smooth Muscle Progenitor Cells Derived from Human Pluripotent Stem Cells Induce Histologic Changes in Injured Urethral Sphincter. J Urol. 2017;198(6):1214. DOI: 10.1016/j.juro.2017.09.040.
  17. Davies BM, Smith J, Rikabi S, Wartolowska K, Morrey M, French A, MacLaren R. A quantitative, multi-national and multi-stakeholder assessment of barriers to the adoption of cell therapies. J Tissue Eng. 2017;8:2041731417724413. DOI: 10.1177/2041731417724413.
  18. Khoury O, Barrios C, Ortega V, Atala A, Murphy SV. Immunomodulatory Cell Therapy to Target Cystic Fibrosis Inflammation. Am J Respir Cell Mol Biol. 2018;58(1):12-20. DOI: 10.1165/rcmb.2017-0160TR.
  19. Kurtzberg J, Atala A. Announcing a New Journal Section: Cord Blood. Stem Cells Transl Med. 2017;6(5):1307-1308. DOI: 10.1002/sctm.17-0077.
  20. Atala A, McAllister TN. Transforming the Approach to Cell-Based Therapies. Stem Cells Transl Med. 2017;6(5):1305-1306. DOI: 10.1002/sctm.17-0064.
  21. Atala A. Advancing the Translation of Stem Cells to Medicine. Stem Cells Transl Med. 2017;6(1):1-2. DOI: 10.1002/sctm.16-0475.
  22. McAllister T, Atala A. Editorial: Future Directions for Stem Cell Banking and Therapy. Curr Stem Cell Res Ther. 2017;12(1):2.
  23. Atala A. Mesenchymal Stem Cells are Recruited and Activated into Carcinoma-Associated Fibroblasts by Prostate Cancer Microenvironment-Derived TGF-β1. J Urol. 2016;196(6):1817. DOI: 10.1016/j.juro.2016.09.014.
  24. Sevastyanov VI. [Tissue engineering and regenerative medicine technologies]. Regenerative medicine and cell technologies. 2014;16(3):93-108. Russian
  25. Nasadyuk HM. [Placental stem cells: biological characteristics and approaches to clinical use]. Cellular and organ transplantology. 2014;2(2):136-139. Ukrainian
  26. Nasadyuk HM. [Biochemical characteristics and approaches to the use of placental extracts in medical practice]. With care for the woman. 2013;4(43):54-56. Ukrainian
  27. Ma Y, Wang Z, Zhang A, Xu F, Zhao N, Xue J. Human placenta-derived mesenchymal stem cells Ameliorate GVHD by MODULATING Th17/Tr1 balance via expression of PD-L2. Life Sciences. 2018;214:98–105. DOI: 10.1016/j.lfs.2018.10.061
  28. Kim SH, Jung J, Cho KJ, Choi JH, Lee HS, Kim GJ. Immunomodulatory effects of Placenta-derived mesenchymal stem cells on T cells by regulation Of FOXP3 EXPRESSION. International Journal of Stem Cells. 2018;11(2):196–204. DOI: 10.15283/ijsc18031.
  29. Noh YK, Du P, Dos Santos Da Costa A, Park K. Induction of chondrogenesis of human placenta-derived mesenchymal stem cells via heparin-grafted human fibroblast derived matrix. Biomater Res. 2018;22:12. DOI: 10.1186/s40824-018-0121-2.
  30. Ma Y, Wang Z, Zhang A, Xu F, Zhao N, Xue J. Human placenta-derived mesenchymal stem cells Ameliorate GVHD by MODULATING Th17/Tr1 balance via expression of PD-L2. Life Sciences. 2018;214:98–105. DOI: 10.1016/j.lfs.2018.10.061.
  31. Kim SH, Jung J, Cho KJ, Choi JH, Lee HS, Kim GJ. Immunomodulatory effects of Placenta-derived mesenchymal stem cells on T cells by regulation Of FOXP3 EXPRESSION. International Journal of Stem Cells. 2018;11(2):196–204. DOI: 10.15283/ijsc18031.
  32. Kim TH, Choi JH, Jun Y, Lim SM, Park S, Paek JY, Lee SH. 3D-cultured human placenta-derived mesenchymal stem cell spheroids enhance ovary function by inducing folliculogenesis. Sci Rep. 2018;8(1):15313. DOI: 10.1038/s41598-018-33575-9.
  33. Naseer N, Bashir S, Latief N, Latif F, Khan SN, Riazuddin S. Human amniotic membrane as differentiating matrix for in vitro chondrogenesis. Regen Med. 2018;13(7):821-832. DOI: 10.2217/rme-2018-0017.
  34. Sun J, Luo Z, Wang G, Wang Y, Wang Y, Olmedo M, Morandi MM. Notch ligand Jagged1 promotes mesenchymal stromal cell-based cartilage repair. Exp Mol Med. 2018;50(9):126. DOI: 10.1038/s12276-018-0151-9.
  35. Lobintseva GS, Gladkikh YV, Lobintsev DV, inventors;
  36. MPK, assignee. The method of operation of the freezer of biological objects. Ukrainian patent UA 14589. 2006 May 15. Int. Cl. F25Д 17/00 А01 1/02. Ukrainian.
  37. Tavasolli M. Embrionic and fetal hemopoiesis, an overview. Blood cells. 1991;17(2):269-281.

Downloads

Published

2021-10-04

How to Cite

Current literary information concerning the properties of stem cells. (2021). Морфологія / Morphologia / Morfologìâ, 15(3), 17–22. https://doi.org/10.26641/1997-9665.2021.3.17-22

Issue

Vol. 15 No. 3 (2021)

Section

Статті

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

 The authors reserve the right to authorship of their work and transfer to the Journal the right to the first publication of this work under the terms of a license Creative commons Attribution 4.0 International (CC BY 4.0), which allows other people to freely distribute the published work with a mandatory reference to the authors of the original work and the first publication of the work in this journal.
        By submitting a manuscript to the editorial office of the Journal ‘Morphologia’ authors agree to transfer the rights to protect and use the manuscript (all supplemental materials, particularly protected objects such as photos, drawings, diagrams, tables, etc.), including the reproduction in the press and distribution via the Internet; translation of the manuscript into any language; export and import of journal copies with the Authors’ article in order to make it available for public. Authors convey the rights mentioned above to the editorial office without any temporal or territorial limitation all over the world. 
        The Authors guarantee that they have the exclusive rights to use the material transferred to editorial office. Editors are not responsible to third parties for contraventions of warranty given by the Authors. The considered rights are transferred to the editorial office since the moment when the current issue is signed for publishing. Reproduction of materials published in the Journal by other individuals and legal entities is possible only with the consent of Editorial office, with the obligatory indication of the full bibliographic reference of the primary publication. The Authors reserve the right to use the published material, its fragments and parts for teaching materials, oral presentations, dissertation thesis prepararion with obligatory bibliographic citation of the original paper. Electron copy of the published article, downloaded from official journal web-site in .pdf format may be put by authors on the official web-site of their institutions, any other official resources with open access.